Showing results (1701-1710 of 1,857) with videos related to

Sort By:
Pageof 186
Peerj|October 18, 2024
The effects of resistance training to near volitional failure on motor unit recruitment during neuromuscular fatigueJonathan P Beausejour, Kevan S Knowles, Jason I Pagan, et al.
Kidney International Reports|January 19, 2026
Clonal Hematopoiesis and Kidney Function in the ASPREE CohortJasmine Singh, Kevan R Polkinghorne, Rory Wolfe, et al.
Blood Advances|August 23, 2021
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemiaEileen Y Hu, Priscilla Do, Swagata Goswami, et al.
Journal for Immunotherapy of Cancer|September 11, 2025
Factors that increase class I MHC expression may contribute to the development of immune checkpoint inhibitor-induced diabetesLilach Aizenbud, Noam Savion Gaiger, Ana Luisa Perdigoto, et al.
Diabetes Care|April 15, 2024
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy TrialsLaura M Jacobsen, David Cuthbertson, Brian N Bundy, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
The structural basis for LRRK2's activation and autoinhibitionAmalia Villagran Suarez, Kathryn S Hatch, Tatyana Bodrug, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 13, 2016
Patient and Caregiver Priorities for Outcomes in Hemodialysis: An International Nominal Group Technique StudyRachel Urquhart-Secord, Jonathan C Craig, Brenda Hemmelgarn, et al.
Canadian Journal of Gastroenterology & Hepatology|June 9, 2017
Allied Health Professional Support in Pediatric Inflammatory Bowel Disease: A Survey from the Canadian Children Inflammatory Bowel Disease Network-A Joint Partnership of CIHR and the CH.I.L.D. FoundationWael El-Matary, Eric I Benchimol, David Mack, et al.
Science Translational Medicine|November 27, 2015
Type 1 diabetes immunotherapy using polyclonal regulatory T cellsJeffrey A Bluestone, Jane H Buckner, Mark Fitch, et al.
Diabetes Care|September 26, 2015
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes AssociationRichard A Insel, Jessica L Dunne, Mark A Atkinson, et al.
Pageof 186